journal article·2022-03-09Open access

Real-Time Observation and Analysis of Magnetomechanical Actuation of Magnetic Nanoparticles in Cells

Arnaud Hillion, Nicolas Hallali, Pascal Clerc, Sara Lopez, Yoann Lalatonne, Camille Noûs, Laurence Motte, Véronique Gigoux, Julian Carrey

Nano Letters· Volume 22· Issue 5

Abstract

The origin of cell death in the magnetomechanical actuation of cells induced by magnetic nanoparticle motion under low-frequency magnetic fields is still elusive. Here, a miniaturized electromagnet fitted under a confocal microscope is used to observe in real time cells specifically targeted by superparamagnetic nanoparticles and exposed to a low-frequency rotating magnetic field. Our analysis reveals that the lysosome membrane is permeabilized in only a few minutes after the start of magnetic field application, concomitant with lysosome movements toward the nucleus. Those events are associated with disorganization of the tubulin microtubule network and a change in cell morphology. This miniaturized electromagnet will allow a deeper insight into the physical, molecular, and biological process occurring during the magnetomechanical actuation of magnetic nanoparticles.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Magnetic and Electromagnetic Effects · Electromagnetic Fields and Biological Effects · Biofield Effects and Biophysics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Laboratoire de Physique et Chimie des Nano-Objets, CNRS UMR5215-INSA, Université de Toulouse III, 31077 Toulouse, France

INSERM ERL1226, Receptology and Targeted Therapy of Cancers, 31432 Toulouse, France

Université Sorbonne Paris Nord and Université de Paris, INSERM, LVTS, F-75018 Paris, France

Laboratoire Cogitamus, Université de Toulouse III, 31000 Toulouse, France

Funding

Institut Th?matique Multi-Organisme Cancer · Canc?rop?le Grand Sud-Ouest · Ligue Nationale Contre le Cancer

References (30)

Show source-provided references
1. 10.1088/0022-3727/36/13/20110.1088/0022-3727/36/13/201 ↗
2. 10.1016/j.addr.2013.09.00610.1016/j.addr.2013.09.006 ↗
3. 10.1016/S1369-7021(11)70163-810.1016/S1369-7021(11)70163-8 ↗
4. 10.1016/j.coph.2014.08.00210.1016/j.coph.2014.08.002 ↗
5. 10.1016/S1748-0132(07)70084-110.1016/S1748-0132(07)70084-1 ↗
6. 10.1007/s13204-013-0216-y10.1007/s13204-013-0216-y ↗
7. 10.1016/j.addr.2008.03.01810.1016/j.addr.2008.03.018 ↗
8. 10.1021/nn404954s10.1021/nn404954s ↗
9. 10.1007/s40204-016-0054-610.1007/s40204-016-0054-6 ↗
10. 10.1088/0957-4484/25/45/45200110.1088/0957-4484/25/45/452001 ↗
11. 10.1038/nnano.2007.41810.1038/nnano.2007.418 ↗
12. 10.1098/rsif.2007.127410.1098/rsif.2007.1274 ↗
13. 10.1021/jp806187r10.1021/jp806187r ↗
14. 10.1063/1.512371610.1063/1.5123716 ↗
15. 10.1002/smll.20190542410.1002/smll.201905424 ↗
16. 10.1016/j.jmmm.2017.12.02410.1016/j.jmmm.2017.12.024 ↗
17. 10.1103/PhysRevB.94.18442010.1103/PhysRevB.94.184420 ↗
18. 10.1021/nn406302j10.1021/nn406302j ↗
19. 10.7150/thno.1835210.7150/thno.18352 ↗
20. 10.3390/cancers1112187310.3390/cancers11121873 ↗
21. 10.1038/srep3356010.1038/srep33560 ↗
22. 10.1039/D1NA00474C10.1039/D1NA00474C ↗
23. 10.1242/jcs.19628710.1242/jcs.196287 ↗
24. 10.1042/BST2014014510.1042/BST20140145 ↗
25. 10.1515/hsz-2016-025210.1515/hsz-2016-0252 ↗
26. 10.1002/jcp.2598010.1002/jcp.25980 ↗
27. 10.1016/j.jconrel.2015.09.03810.1016/j.jconrel.2015.09.038 ↗
28. 10.1038/ncb332410.1038/ncb3324 ↗
29. 10.1074/jbc.M111.28553610.1074/jbc.M111.285536 ↗
30. 10.18632/oncotarget.966110.18632/oncotarget.9661 ↗